
Globus Medical, Inc.
Globus Medical, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $10.2B. Its FinScore is 73/100; its highest-scoring layer is Value (74) and its lowest is Momentum (54). The shares trade at 19.2x trailing earnings and are down 12% year to date.
Share price performance
About Globus Medical, Inc.
www.globusmedical.comGlobus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Devices
- HQ
- United States
- Fiscal year-end
- December
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 74 days ago
- Market cap
- $10.2B
- Shares outstanding
- 134.3M
- P/E (TTM)
- 19.2x
- Beta (issuer)
- 0.96
- Revenue (latest FY)
- $2.9B
Revenue breakdown
- Spine93.9%$2.4B
- Emerging Technology6.1%$154.0M
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Globus Medical, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.